[Prognostic factors in liver tumors]

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Background:

• Hepatocellular carcinoma (HCC) presents a dismal prognosis, with cure primarily achievable through resection or transplantation.
• Prognosis is heavily influenced by the anatomic extent of the disease and the possibility of complete surgical removal.

Purpose of the Study:

• To review prognostic factors influencing survival in hepatocellular carcinoma patients post-resection or transplantation.
• To identify key clinical and pathological features that impact patient outcomes beyond initial surgical staging.

Main Methods:

• Systematic review of studies analyzing prognostic significance of various factors in HCC.
• Inclusion of univariate and multivariate analyses of clinical, pathological, and molecular data.
• Emphasis on factors evaluated after resection or transplantation.

Main Results:

• Tumor extent (TNM staging) and resection for cure (R classification) are the most significant prognostic indicators.
• Clinical factors like performance status and pathological features such as histological type and cirrhosis show variable importance.
• Molecular pathology factors have not yet demonstrated superior prognostic value compared to TNM and R classification.
• For unresectable HCC, ascites, toxic syndrome, and laboratory values (bilirubin, BUN, albumin) are independent predictors of survival.

Conclusions:

• TNM staging and R classification remain paramount for predicting HCC patient survival.
• While other factors contribute, their prognostic impact is less consistent or validated than established staging systems.
• Further research into molecular markers may refine prognostication but must demonstrate superiority over current standards.